| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.22B | 1.20B | 1.15B | 1.09B | 1.12B | 1.11B |
| Gross Profit | 893.35M | 940.31M | 903.38M | 949.75M | 748.55M | 490.66M |
| EBITDA | 893.35M | 929.22M | 903.38M | 949.92M | 746.23M | 490.66M |
| Net Income | 659.82M | 688.07M | 665.51M | 704.16M | 546.68M | 370.42M |
Balance Sheet | ||||||
| Total Assets | 6.88B | 6.52B | 6.19B | 5.71B | 5.87B | 5.65B |
| Cash, Cash Equivalents and Short-Term Investments | 2.28B | 2.13B | 5.90B | 5.40B | 5.69B | 5.50B |
| Total Debt | 744.11M | 743.05M | 745.42M | 742.83M | 740.42M | 738.16M |
| Total Liabilities | 1.56B | 1.53B | 1.56B | 1.61B | 1.76B | 1.77B |
| Stockholders Equity | 5.32B | 5.00B | 4.63B | 4.10B | 4.11B | 3.88B |
Cash Flow | ||||||
| Free Cash Flow | 704.38M | 686.26M | 632.04M | 567.13M | -113.53M | 704.35M |
| Operating Cash Flow | 704.38M | 686.26M | 632.04M | 560.51M | 572.12M | 704.35M |
| Investing Cash Flow | -373.35M | -320.51M | -229.40M | -220.25M | -398.78M | -1.14B |
| Financing Cash Flow | -460.82M | -382.00M | -300.73M | -252.31M | -200.29M | 300.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $5.84B | 9.29 | 12.75% | 2.02% | 2.40% | 1.18% | |
81 Outperform | $6.16B | 9.27 | 12.35% | 1.88% | 2.78% | -0.50% | |
79 Outperform | $3.02B | 8.09 | 16.17% | ― | 8.86% | 9.51% | |
78 Outperform | $6.16B | 8.77 | 14.40% | 1.89% | 2.20% | 9.90% | |
74 Outperform | $6.52B | 13.74 | 9.28% | 3.58% | 25.99% | 426.44% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $4.46B | 8.21 | 12.56% | 2.78% | -3.68% | 3.65% |
On February 3, 2026, Enact Holdings reported fourth-quarter and full-year 2025 results showing continued profitability and capital strength, with Q4 GAAP net income of $177 million, or $1.22 per diluted share, and adjusted operating income of $179 million, or $1.23 per diluted share. For 2025, the company generated $674 million in net income, maintained a solid adjusted operating return on equity of 13.3%, and grew primary insurance in-force to $273 billion, up 2% year over year. Losses incurred fell to $18 million in the fourth quarter, driving a loss ratio of 7%, helped by a $60 million net reserve release tied to favorable cure performance and lower expected claim rates, while elevated persistency and stable net premiums earned supported earnings despite a challenging housing backdrop. Enact also underscored its robust capital position, with PMIERs sufficiency of 162% (about $1.9 billion) and book value per share of $37.66, and returned $503 million to shareholders in 2025 through dividends and $382 million of share repurchases. In a further demonstration of shareholder-return focus, the board on February 3, 2026 authorized a new share repurchase program of up to $500 million of common stock and the company entered into a stock buyback agreement with its majority owner Genworth Financial, moves that reinforce capital management discipline and signal confidence in the company’s long-term earnings power.
The most recent analyst rating on (ACT) stock is a Hold with a $40.00 price target. To see the full list of analyst forecasts on Enact Holdings stock, see the ACT Stock Forecast page.